SP140 Antikörper (Middle Region)
Kurzübersicht für SP140 Antikörper (Middle Region) (ABIN954896)
Target
Alle SP140 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 279-309, Middle Region
-
Spezifität
- This antibody recognizes Human SP140 (Center).
-
Aufreinigung
- Protein A column, followed by peptide affinity purification
-
Immunogen
- KLH conjugated synthetic peptide between 279-309 amino acids from the Central region of Human SP140. Genename: SP140
-
Isotyp
- Ig Fraction
-
-
-
-
Applikationshinweise
- Optimal working dilution should be determined by the investigator.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 0.25 mg/mL
-
Buffer
- PBS containing 0.09 % (W/V) Sodium Azide as preservative
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Handhabung
- Avoid repeated freezing and thawing.
-
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store undiluted at 2-8 °C for one month or (in aliquots) at -20 °C for longer.
-
-
- SP140 (SP140 Nuclear Body Protein (SP140))
-
Andere Bezeichnung
- SP140
-
Hintergrund
- Component of the nuclear body, also known as nuclear domain 10, PML oncogenic domain, and KR body. May be involved in the pathogenesis of acute promyelocytic leukemia and viral infection.Synonyms: LYSP100, Nuclear antigen Sp-140, Speckled 140 kDa
-
Molekulargewicht
- 98223 Da
-
Gen-ID
- 11262
-
NCBI Accession
- NP_009168
Target
-